EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,925,288 | +9.9% | 1,186,512 | -3.9% | 0.02% | +18.8% |
| Q2 2023 | $23,587,894 | -5.4% | 1,234,322 | -3.9% | 0.02% | -11.1% |
| Q1 2023 | $24,923,915 | +22.0% | 1,284,076 | +0.9% | 0.02% | +20.0% |
| Q4 2022 | $20,422,402 | +3.7% | 1,273,217 | +1.4% | 0.02% | -6.2% |
| Q3 2022 | $19,692,000 | -25.6% | 1,255,825 | -1.3% | 0.02% | -20.0% |
| Q2 2022 | $26,481,000 | +8.6% | 1,271,865 | +18.2% | 0.02% | +33.3% |
| Q1 2022 | $24,387,000 | +22.9% | 1,075,705 | -0.9% | 0.02% | +25.0% |
| Q4 2021 | $19,845,000 | -14.3% | 1,085,646 | -0.9% | 0.01% | -20.0% |
| Q3 2021 | $23,152,000 | +15.8% | 1,095,220 | -0.2% | 0.02% | +15.4% |
| Q2 2021 | $19,992,000 | -17.8% | 1,097,233 | +1.9% | 0.01% | -23.5% |
| Q1 2021 | $24,332,000 | +31.0% | 1,077,103 | +16.4% | 0.02% | +21.4% |
| Q4 2020 | $18,572,000 | -17.7% | 925,400 | +0.3% | 0.01% | -26.3% |
| Q3 2020 | $22,560,000 | +0.1% | 922,726 | -2.8% | 0.02% | -5.0% |
| Q2 2020 | $22,543,000 | +40.6% | 949,587 | +2.0% | 0.02% | +11.1% |
| Q1 2020 | $16,028,000 | -31.0% | 930,771 | -29.4% | 0.02% | -5.3% |
| Q4 2019 | $23,236,000 | -0.2% | 1,318,727 | +0.2% | 0.02% | -9.5% |
| Q3 2019 | $23,274,000 | -18.5% | 1,315,979 | -1.5% | 0.02% | -19.2% |
| Q2 2019 | $28,547,000 | -9.9% | 1,335,811 | +0.3% | 0.03% | -13.3% |
| Q1 2019 | $31,698,000 | +22.3% | 1,331,871 | +1.1% | 0.03% | +7.1% |
| Q4 2018 | $25,917,000 | +9.2% | 1,317,606 | -1.6% | 0.03% | +33.3% |
| Q3 2018 | $23,737,000 | -11.9% | 1,339,549 | +7.0% | 0.02% | -16.0% |
| Q2 2018 | $26,953,000 | +1237.0% | 1,252,456 | +1276.2% | 0.02% | +1150.0% |
| Q1 2018 | $2,016,000 | -23.4% | 91,006 | +5.1% | 0.00% | 0.0% |
| Q4 2017 | $2,631,000 | +123.5% | 86,561 | +78.1% | 0.00% | +100.0% |
| Q3 2017 | $1,177,000 | -18.6% | 48,595 | -17.3% | 0.00% | 0.0% |
| Q2 2017 | $1,446,000 | -56.9% | 58,742 | -62.1% | 0.00% | -75.0% |
| Q1 2017 | $3,358,000 | +45.2% | 154,968 | -0.1% | 0.00% | +33.3% |
| Q4 2016 | $2,312,000 | +156.9% | 155,076 | +120.5% | 0.00% | +200.0% |
| Q3 2016 | $900,000 | +191.3% | 70,327 | +77.6% | 0.00% | – |
| Q2 2016 | $309,000 | +94.3% | 39,608 | -0.2% | 0.00% | – |
| Q1 2016 | $159,000 | -28.1% | 39,678 | +1.4% | 0.00% | – |
| Q4 2015 | $221,000 | +18.8% | 39,123 | +18.0% | 0.00% | – |
| Q3 2015 | $186,000 | +67.6% | 33,166 | +11.9% | 0.00% | – |
| Q2 2015 | $111,000 | +40.5% | 29,632 | -46.3% | 0.00% | – |
| Q4 2014 | $79,000 | -20.2% | 55,183 | -14.9% | 0.00% | – |
| Q3 2014 | $99,000 | -28.3% | 64,876 | +59.0% | 0.00% | – |
| Q2 2014 | $138,000 | -36.4% | 40,803 | -33.4% | 0.00% | – |
| Q1 2014 | $217,000 | -31.8% | 61,285 | +18.2% | 0.00% | -100.0% |
| Q4 2013 | $318,000 | +5.3% | 51,832 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $302,000 | +20.3% | 51,832 | -6.1% | 0.00% | 0.0% |
| Q2 2013 | $251,000 | – | 55,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |